Clinical trials
Phase 1 Insulin Resistance trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
115 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 3 |
| 2004 | 2 |
| 2005 | 4 |
| 2006 | 5 |
| 2007 | 3 |
| 2008 | 6 |
| 2009 | 9 |
| 2010 | 4 |
| 2011 | 6 |
| 2012 | 6 |
| 2013 | 5 |
| 2014 | 5 |
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 6 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 6 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 5 |
| 2025 | 5 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 79 |
| Recruiting | 13 |
| Withdrawn | 7 |
| Terminated | 6 |
| Active, not recruiting | 4 |
| Unknown status | 3 |
| Not yet recruiting | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Columbia University | 11 |
| Vanderbilt University Medical Center | 6 |
| Stanford University | 5 |
| Halozyme Therapeutics | 4 |
| Mayo Clinic | 4 |
| Pennington Biomedical Research Center | 4 |
| University of Missouri-Columbia | 3 |
| University of Virginia | 3 |
| Washington University School of Medicine | 3 |
| Albert Einstein College of Medicine | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Insulin Resistance | 115 |
| Obesity | 29 |
| Diabetes Mellitus, Type 2 | 20 |
| Diabetes Mellitus | 17 |
| Diabetes Mellitus, Type 1 | 12 |
| Hyperinsulinism | 11 |
| Prediabetic State | 8 |
| Non-alcoholic Fatty Liver Disease | 7 |
| Inflammation | 5 |
| Metabolic Syndrome | 5 |
Trials
Showing 1 to 25 of 115. Each trial links to its page on Pharma Observatory.
15 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.